Your shopping cart is currently empty

YM 133 (IMC-XV) is a semi-synthetic macrolide antibiotic with potent bactericidal activity. It is effective against strains of staphylococci, streptococci, Bacteroides, and Clostridia that are resistant to erythromycin, josamycin, and rokitamycin (MIC≥ 100 μg/mL). Additionally, YM 133 exhibits excellent activity against macrolide-resistant strains and anaerobic bacteria, making it valuable for antibacterial research.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | YM 133 (IMC-XV) is a semi-synthetic macrolide antibiotic with potent bactericidal activity. It is effective against strains of staphylococci, streptococci, Bacteroides, and Clostridia that are resistant to erythromycin, josamycin, and rokitamycin (MIC≥ 100 μg/mL). Additionally, YM 133 exhibits excellent activity against macrolide-resistant strains and anaerobic bacteria, making it valuable for antibacterial research. |
| Synonyms | IMC-XV |
| Molecular Weight | 1064.27 |
| Formula | C55H85NO19 |
| Cas No. | 103360-00-5 |
| Smiles | O=CCC1CC(C(=O)C=CC(=CC(COC2OC(C)C(O)C(OC)C2OC)C(OC(=O)CC(O)C(C)C1OC3OC(C)C(OC4OC(C)C(OC(=O)CC5=CC=C(OC)C=C5)C(O)(C)C4)C(N(C)C)C3O)CC)C)C |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.